4//SEC Filing
Bamforth John Philip 4
Accession 0001818382-25-000109
CIK 0001818382other
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 4:30 PM ET
Size
5.4 KB
Accession
0001818382-25-000109
Insider Transaction Report
Form 4
Humacyte, Inc.HUMA
Bamforth John Philip
Director
Transactions
- Award
Stock Options (right to buy)
2025-06-12+80,000→ 80,000 totalExercise: $2.41Exp: 2035-06-12→ Common Stock (80,000 underlying)
Footnotes (1)
- [F1]The first 25% of the option becomes exercisable on June 12, 2026, after which 1/48 of the option will become exercisable on the 12th of each month through June 12, 2029.
Documents
Issuer
Humacyte, Inc.
CIK 0001818382
Entity typeother
Related Parties
1- filerCIK 0002026341
Filing Metadata
- Form type
- 4
- Filed
- Jun 15, 8:00 PM ET
- Accepted
- Jun 16, 4:30 PM ET
- Size
- 5.4 KB